SenaBio is a Canadian research supply company. We don’t manufacture — we source, vet, verify and stock. Here is exactly what that involves.
Before we buy anything we check who we’re actually dealing with — registered business scope, whether they run a facility or simply resell someone else’s output, how long they’ve operated, and what documentation they can produce. A surprising number of “manufacturers” in this industry are trading companies with a website.
Every lot has to come with its own analysis from the manufacturer, covering identity, purity and quantity. We check that the documentation is internally consistent and that it corresponds to the lot we’re actually buying — not a different production run.
When a batch physically arrives, we send a sample to a Canadian laboratory for independent analysis. We are not relying solely on paperwork produced by the party selling to us.
A product stays marked "Coming Soon" on our shelf until that analysis comes back. If a batch doesn’t meet spec, it doesn’t get listed — which is why our catalogue grows slowly.
Most suppliers sell ten-unit kits. We buy the lot and split it into single units, so trying one bottle is a real option instead of a case-sized commitment.
This market has a trust problem. Independent testing programmes have repeatedly found that a meaningful share of research peptide samples fail on purity, identity or quantity — most often quantity, where a product is clean but there is simply less of it than the label says. Meanwhile almost every storefront uses the same three words: pure, tested, verified.
We decided the useful thing to build wasn’t another storefront saying those words. It was a supplier that does the verification step itself, in Canada, and doesn’t list what it hasn’t checked.
We won’t tell you what a compound will do for your body. We won’t publish testimonials or before-and-after results. We won’t cite studies we haven’t read or quote figures without a source. If research was done in animals, we say animals.
Our compound library describes what each peptide is and what the published research investigated. That’s information, not a promise. For a deeper look at our first compound, see the BPC-157 research guide.
Early, and building carefully. Small catalogue, single-unit sales, Canadian stock. We’d rather have four products we’ve verified than forty we haven’t.